Obesity Trial, Recruiting NCT04583514 Sponsor: Pennington Biomedical Research Center Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT04583514
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a man or a woman who has not yet gone through menopause
  • You are between 18 and 42 years old
  • Your body mass index (a measure of body weight relative to height) falls roughly between 23 and 35
  • You are willing to drink a special type of water (called deuterium-labeled water) every day for 8 weeks
  • You are willing to be randomly placed into one of two groups in the study
  • If you are a woman and not using hormonal birth control (such as the pill, ring, injection, or implant), you are willing to use another reliable method to prevent pregnancy for the entire study
  • You are willing to follow all study instructions and attend all required appointments
  • You agree to keep your exercise and physical activity at the same level throughout the study
  • You are willing to have some of your blood stored for possible future research

Who may not be able to join:

  • Your weight has gone up or down by about 5% or more in the last 3 months
  • You have been diagnosed with Type 1 or Type 2 diabetes, or your fasting blood sugar level is above 110 mg/dL
  • Your blood pressure is consistently above 140/90
  • You have a serious disease affecting a major organ such as your heart, kidneys, lungs, thyroid, or liver, or you have abnormal liver test results that the study doctor considers significant
  • You have reported testing positive for HIV, hepatitis B, or hepatitis C
  • You have ever had or currently have an eating disorder
  • You regularly take certain medications, including steroids, beta-blockers, antipsychotics, or other medicines known to significantly affect weight (confirm with trial site)
  • You regularly take prescription or over-the-counter weight loss medications
  • You have been taking antidepressant medication for less than 3 months
  • You currently smoke or use tobacco products and cannot stop during the in-person study visits
  • You have previously had weight-loss (bariatric) surgery or other surgery for obesity
  • You have been diagnosed with cancer in the last 5 years (certain minor skin cancers may be acceptable — confirm with trial site)
  • You are currently pregnant, breastfeeding, or planning to become pregnant in the next 6 months
  • You have had a full or partial hysterectomy (surgical removal of the uterus)
  • You have been diagnosed with polycystic ovary syndrome (PCOS)
  • You have been diagnosed with a psychotic condition

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ursula White, Ph.D., Pennington Biomedical Research Center

Phone: 225-763-2656

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Pennington Biomedical Research Center
Registry
ClinicalTrials.gov
Start date
15 September 2020
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Adipose tissue expansion and remodeling -- in vivo adipocyte formation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov